HSD17B11
Estradiol 17-beta-dehydrogenase 11
Also known as: 17-BETA-HSD11, 17-BETA-HSDXI, DHB11_HUMAN, DHRS8, PAN1B, RetSDR2, SDR16C2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NBQ5
- Gene
- HSD17B11
- Ensembl
- ENSG00000198189
- Chromosome
- 4
- Canonical length
- 300 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Lipid droplets
OverviewNCBI Gene
Short-chain alcohol dehydrogenases, such as HSD17B11, metabolize secondary alcohols and ketones (Brereton et al., 2001 [PubMed 11165019]).[supplied by OMIM, Jun 2009]
Canonical amino-acid sequenceUniProt
300 residues, UniProt reviewed canonical sequence.
>Q8NBQ5|HSD17B11
1 MKFLLDILLL LPLLIVCSLE SFVKLFIPKR RKSVTGEIVL ITGAGHGIGR LTAYEFAKLK
61 SKLVLWDINK HGLEETAAKC KGLGAKVHTF VVDCSNREDI YSSAKKVKAE IGDVSILVNN
121 AGVVYTSDLF ATQDPQIEKT FEVNVLAHFW TTKAFLPAMT KNNHGHIVTV ASAAGHVSVP
181 FLLAYCSSKF AAVGFHKTLT DELAALQITG VKTTCLCPNF VNTGFIKNPS TSLGPTLEPE
241 EVVNRLMHGI LTEQKMIFIP SSIAFLTTLE RILPERFLAV LKRKISVKFD AVIGYKMKAQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HSD17B11 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 272 nTPM
Expression across tissuesHPA
Tissue
- small intestine: 272 nTPM
- liver: 226 nTPM
- duodenum: 204 nTPM
- rectum: 137 nTPM
- colon: 131 nTPM
- bone marrow: 104 nTPM
Single-cell type
- neutrophils: 174 nCPM
- enterocytes: 148 nCPM
- neutrophil progenitors: 88 nCPM
- microglia: 68 nCPM
- transitional alveolar cells: 49 nCPM
- fibro-adipogenic progenitors: 48 nCPM
Immune cell
- neutrophil: 772 nTPM
- basophil: 594 nTPM
- eosinophil: 444 nTPM
- classical monocyte: 202 nTPM
- total PBMC: 172 nTPM
- intermediate monocyte: 143 nTPM
Brain region
- white matter: 30 nTPM
- medulla oblongata: 25 nTPM
- cerebellum: 23 nTPM
- spinal cord: 23 nTPM
- pons: 21 nTPM
- choroid plexus: 21 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.46
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.84
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- estradiol 17-beta-dehydrogenase [NAD(P)+] activity
- oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
- steroid dehydrogenase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HSD17B11 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HSD17B11 as an antibody target. Whether an autoantibody or antibody against HSD17B11 could matter depends on whether native HSD17B11 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HSD17B11 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HSD17B11 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...